PubRank

A Montagnani

Author PubWeight™ 19.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma. Cancer 2001 1.43
2 Hematuria and rectal bleeding in the child with Klippel and Trenaunay syndrome. Ann Surg 1976 1.31
3 Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids. Br J Cancer 2006 1.08
4 Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int 2003 1.07
5 Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane. Bone 2006 0.99
6 Bone ultrasonography at phalanxes in patients with Rett syndrome: a 3-year longitudinal study. Bone 2007 0.96
7 Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab 1998 0.93
8 Effects of pravastatin treatment on vitamin D metabolites. Clin Ther 1995 0.91
9 Bone turnover and the response to alendronate treatment in postmenopausal osteoporosis. Calcif Tissue Int 1999 0.87
10 Proteus syndrome. Ultrastructural study of linear verrucous and depigmented nevi. J Am Acad Dermatol 1991 0.85
11 Acanthocytosis, retinitis pigmentosa, pallidal degeneration. Report of two cases without serum lipid abnormalities. J Neurol Sci 1996 0.83
12 Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study. Osteoporos Int 2002 0.83
13 [A family with the EEC syndrome (ectrodactily, ectodermal dysplasia clefting syndrome): clinical variability and genetic counseling]. J Fr Ophtalmol 1986 0.83
14 Osteogenesis imperfecta: bone turnover, bone density, and ultrasound parameters. Calcif Tissue Int 1999 0.83
15 Adrenal steroid-genetic activity in subjects with alopecia totalis or subtotalis diffuse alopecia and alopecia areata. Ital Gen Rev Dermatol 1981 0.82
16 Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. Osteoporos Int 2004 0.81
17 Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis. J Endocrinol Invest 2005 0.79
18 Teriparatide's effects on quantitative ultrasound parameters and bone density in women with established osteoporosis. Osteoporos Int 2006 0.78
19 The combined use of ultrasound and densitometry in the prediction of vertebral fracture. Br J Radiol 1997 0.78
20 Quantitative ultrasound and bone mineral density in patients with primary hyperparathyroidism before and after surgical treatment. Osteoporos Int 2000 0.77
21 Diabetes mellitus and skin diseases in childhood. Dermatologica 1985 0.77
22 Erythrocyte antioxidant system in Down syndrome. Am J Med Genet Suppl 1990 0.77
23 Bone ultrasonography in glucocorticoid-induced osteoporosis. Osteoporos Int 2004 0.76
24 [Oral administration of new drugs in the treatment of recent syphilis]. Minerva Dermatol 1967 0.75
25 [The importance of oblique radiography in injuries of the lower limb]. Chir Organi Mov 1982 0.75
26 [Habitual voluntary and atraumatic posterior dislocation of the shoulder. Description of a case]. Chir Organi Mov 1984 0.75
27 Ketoconazole treatment of chronic mucocutaneous candidiasis. Drugs Exp Clin Res 1986 0.75
28 Alpha recombinant interferon in the treatment of mycosis fungoides (MF). Haematologica 1987 0.75
29 [Statistical findings on the curability of syphilis]. Minerva Dermatol 1967 0.75
30 [Observations on psoriasis in juvenile age]. Dermatol Wochenschr 1967 0.75
31 [Postoperative fractures of the femur with hip prosthesis]. Chir Organi Mov 1985 0.75
32 [Reconstruction of the point of the postero-internal angle and eventual associated complementary intervention in chronic antero-medial capsulo-ligament lesions of the knee (38 cases with an average 4 years' control]. Chir Organi Mov 1988 0.75
33 [Relationship of enteropathic acrodermatitis, celiac disease and kwashiorkor]. Dermatol Int 1968 0.75
34 [Clinical aspects of male infertility]. Minerva Dermatol 1967 0.75
35 [Skin localization of tumors]. Minerva Med 1971 0.75
36 [Genetic problems of kidney cysts]. Minerva Urol Nefrol 1988 0.75
37 [Lateral chronic instability of the knee. I]. Chir Organi Mov 1982 0.75
38 [Use of hydrocolloids in ulcers of the legs and burns]. G Ital Dermatol Venereol 1988 0.75
39 [A case of neurinoma of the posterior tibial nerve]. Chir Organi Mov 1984 0.75
40 [Considerations on some genealogical trees of psoriasic families]. G Ital Dermatol Minerva Dermatol 1969 0.75
41 [Rare case of bilateral non-ossification of the epiphyseal nucleus of the tuberculum of the first rib]. Chir Organi Mov 1984 0.75
42 [Wear and tear behavior of polyethylene for articular prostheses]. Chir Organi Mov 1985 0.75
43 Dermatological aspects of porphyrias. Panminerva Med 1966 0.75
44 [Importance of Chlamydia trachomatis in the etiology of nongonococcal urethritis]. Clin Ter 1980 0.75
45 [Eosinophilic granuloma- histiocytosis X]. G Ital Dermatol Minerva Dermatol 1968 0.75
46 [Diabetic osteoarthropathy. Considerations on a clinical case]. G Ital Dermatol Venereol 1985 0.75
47 [Experience with replacement prosthesis performed at the Rizzoli Institute]. Chir Organi Mov 1983 0.75
48 [Cutaneous epitheliomatosis and porphyrins]. Minerva Dermatol 1968 0.75
49 [Treatment of chronic venous insufficiency with phlebotropic drugs]. Clin Ter 1984 0.75
50 Polymorphism of the locus CHE1 of pseudocholinesterase in Italy. Gene Geogr 1988 0.75
51 Usefulness of ultrasound in Sudeck's atrophy of the foot. Calcif Tissue Int 1998 0.75
52 [Rifamycin SV in the treatment of herpes zoster. Results of a multicenter clinical investigation]. G Ital Dermatol Venereol 1985 0.75
53 Bone alkaline phosphatase measured with a new immunoradiometric assay in patients with metabolic bone diseases. Eur J Clin Invest 1996 0.75
54 [Familial aspects of psoriasis. Statistical findings]. G Ital Dermatol Minerva Dermatol 1969 0.75
55 Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study. Clin Endocrinol (Oxf) 1997 0.75
56 Cytoskeleton and extracellular matrix of cutaneous vessels in inflammatory processes: immunomorphological study. Appl Pathol 1988 0.75
57 [Etiopathogenetic research on epiphysiolysis]. Chir Organi Mov 1982 0.75
58 [Minoxidil. Objectivity and criticism]. G Ital Dermatol Venereol 1989 0.75
59 [Supracotyloid osteonecrosis in the adult]. Chir Organi Mov 1984 0.75
60 Preliminary results of a clinical trial relative to the use of rifamycin SV in the treatment of herpes zoster. J Int Med Res 1980 0.75
61 [Evaluation of the absorption of salicylic acid in keratolytic therapy]. G Ital Dermatol Venereol 1986 0.75
62 [Dermatogenic enteropathy]. G Ital Dermatol Venereol 1984 0.75
63 [Long-term follow-up of ceramic hip prostheses produced as a result of Italo-Austrian cooperation]. Chir Organi Mov 1984 0.75
64 [Male sterility as a symptom of some diseases in the field of internal medicine]. G Ital Dermatol Minerva Dermatol 1970 0.75
65 [Histiocytosis X with multiple cutaneous and mucous locations. Apropos of 2 clinical cases]. Minerva Dermatol 1967 0.75
66 [Clinical and genetic study of a family with hereditary essential myoclonus]. Rev Neurol (Paris) 1987 0.75
67 [A case of erysipeloid]. G Ital Dermatol Venereol 1987 0.75
68 [Dose/effect correlation in topical minoxidil therapy of androgenic alopecia]. G Ital Dermatol Venereol 1988 0.75
69 [Peristomal dermatitis]. G Ital Dermatol Venereol 1984 0.75
70 [Morphological data on teratospermia]. Minerva Med 1969 0.75
71 [Curability and cure of syphilis]. Minerva Med 1973 0.75
72 [Cystic degeneration (geode) of the acetabulum]. Chir Organi Mov 1984 0.75